Flying The Web For News.
  • Career Exam Study
    Career Exam Study
  • US Politics
    US Politics
  • E-commerce Guide
    E-commerce Guide
  • Dropshipping Guide
    Dropshipping Guide
  • Microsoft Exam
    Microsoft Exam
  • IT Career News
    IT Career News

Article Tools/Herramientas de artículos

+ Larger Font/Fuente más grande | - Smaller Font/Fuente más pequeña




Globe NewsWire News Distribution Service


Pandora A/S has been notified of transactions in the Pandora A/S share by a person discharging managerial responsibilities and/or closely associated persons. Anders Boyer, Chief Financial Officer of Pandora A/S, has reported the sale of 40,000 shares at a total consideration of DKK 54,104,668.00, and now holds a total of 123,108 shares in the company.


Posted: 2025-02-06 11:02:00

Get Full News Story On GlobeNewsWire Press Release Service



Listen to this article. Speaker link opens in a new window.
Text To Speech BETA Test Version.



More News From Current Category Plus Bonus Features From The Web

Press Release: Best Delta 8 Gummies of 2025: Area 52 Named #1 Edible by Oregon Observer

Mon, 07 Jul 2025 04:07:52 +0000

Las Vegas, NV, July 06, 2025 (GLOBE NEWSWIRE) -- In a landmark achievement that solidifies Area 52's position as the Delta 8 market leader, The Oregon Observer's extensive 2025 cannabis edibles review has awarded the top Delta 8 gummy rankings to Area 52's innovative product line. This unprecedented sweep demonstrates the brand's unwavering commitment to…

Read More ...


Press Release: Abinopharm, Inc. and EGT Synbio Announce Successful Human Clinical Trials on Oral L-Ergothioneine (Dr.Ergo®) for Skin Health

Mon, 07 Jul 2025 01:07:50 +0000

SHELTON, Conn., July 06, 2025 (GLOBE NEWSWIRE) -- Abinopharm, Inc., an innovative nutritional and biopharmaceutical company based in Shelton, Connecticut, USA, is pleased to announce that its partner, EGT Synbio, headquartered in Shanghai, China, has successfully completed two human clinical trials evaluating the effects of oral L-ergothioneine (Dr.Ergo®) on skin health. Abinopharm, Inc. is the…

Read More ...


Press Release: Apogee Therapeutics to Host Conference Call to Report Part A 16-Week Data from the Phase 2 APEX Trial of APG777 in Patients with Moderate-to-Severe Atopic Dermatitis on July 7, 2025

Sun, 06 Jul 2025 22:07:52 +0000

SAN FRANCISCO and BOSTON, July 06, 2025 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc., (Nasdaq: APGE), a clinical-stage biotechnology company advancing novel biologics with the potential for differentiated efficacy and dosing in the largest inflammatory and immunology (I&I) markets, including for the treatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD)…

Read More ...


Press Release: BJMINING Unleashes AI-Powered Energy Arbitrage to Revolutionize Bitcoin Mining Profitability

Sun, 06 Jul 2025 19:07:52 +0000

London, July 06, 2025 (GLOBE NEWSWIRE) -- With Bitcoin currently trading at $107,000 — up 60% year-to-date—many U.S.-based mining operations are facing existential threats as single-coin production costs soar to $137,000. In stark contrast, BJMINING, the UK-based cloud mining giant founded in 2015, has reduced its breakeven threshold to $68,000 by leveraging AI-powered dynamic energy…

Read More ...


Press Release: Backblaze Investor News: If You Have Suffered Losses in Backblaze, Inc. (NASDAQ: BLZE), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

Sun, 06 Jul 2025 16:07:53 +0000

NEW YORK, July 06, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Backblaze, Inc. (NASDAQ: BLZE) resulting from allegations that Backblaze may have issued materially misleading business information to the investing public.

Read More ...


Pandora A/S (PNDORA.CO) Latest Press Releases & Corporate News - Yahoo Finance

Sat, 26 Apr 2025 09:59:00 GMT
In accordance with section 30 of the Capital Markets Act, Pandora A/S hereby announce that Parvus Asset Management Europe Limited has notified control of 4,124,466 shares, corresponding to 5.03% ...

TRADING IN PANDORA A/S SHARES BY BOARD MEMBERS, EXECUTIVES AND ASSOCIATED PERSONS - Nasdaq

Tue, 13 Feb 2024 03:56:00 GMT
Alexander Lacik, Chief Executive Officer of Pandora A/S, has reported the sale of 35,000 shares at a total consideration of DKK 37,594,450.00, and now holds a total of 257,205 shares in the company.










Blow Us A Whistle




Related Product Search/Búsqueda de productos relacionados